2023 annual financial data
CNS Pharmaceuticals 2023 Operating margin
CNS Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -18,865,108 USD and net income was -18,851,226 USD.
Operating cash flow was -14,140,031 USD.
Get free CNS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -18,865,108 USD
- Net income
- -18,851,226 USD
- Operating cash flow
- -14,140,031 USD